Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
Cho J, Shen L, Huq M, Kandane-Rathnayake R, Golder V, Louthrenoo W, Chen YH, Hamijoyo L, Luo SF, Wu YJ, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake D, Chan M, Kikuchi J, Takeuchi T, Bae SC, Oon S, O'Neill S, Goldblatt F, Ng KPL, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Navarra SV, Lau CS, Hoi A, Morand EF, Nikpour M, Lateef A; Asia-Pacific Lupus Collaboration.
Lancet Rheumatol. 2023 Oct;5(10):e584-e593. doi: 10.1016/S2665-9913(23)00209-6. Epub 2023 Sep 12.
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.
Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E 3rd.
N Engl J Med. 1994 Oct 6;331(14):896-903. doi: 10.1056/NEJM199410063311402.
SANI clinical remission definition: a useful tool in severe asthma management.
Canonica GW, Bagnasco D, Bondi B, Varricchi G, Paoletti G, Blasi F, Paggiaro P, Braido F; SANI study group.
J Asthma. 2024 Dec;61(12):1593-1600. doi: 10.1080/02770903.2024.2376919. Epub 2024 Jul 23.
Spanish Consensus on Remission in Asthma (REMAS).
Álvarez-Gutiérrez FJ, Casas-Maldonado F, Soto-Campos G, Blanco-Aparicio M, Delgado J, Galo AP, Quirce S, Plaza V; REMAS GROUP.
Arch Bronconeumol. 2024 Aug;60(8):503-509. doi: 10.1016/j.arbres.2024.04.002. Epub 2024 Apr 23.
Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year Period.
Medina-Quiñones CV, Ramos-Merino L, Ruiz-Sada P, Isenberg D.
Arthritis Care Res (Hoboken). 2016 Jul;68(7):981-7. doi: 10.1002/acr.22774.
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, Assad L, Poniecka A, Hennessy B, Green M, Buzdar AU, Singletary SE, Hortobagyi GN, Pusztai L.
J Clin Oncol. 2007 Oct 1;25(28):4414-22. doi: 10.1200/JCO.2007.10.6823. Epub 2007 Sep 4.
Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation.
Dimitriou M, Mortera-Blanco T, Tobiasson M, Mazzi S, Lehander M, Högstrand K, Karimi M, Walldin G, Jansson M, Vonlanthen S, Ljungman P, Langemeijer S, Yoshizato T, Hellström-Lindberg E, Woll PS, Jacobsen SEW.
Blood. 2024 Mar 14;143(11):953-966. doi: 10.1182/blood.2023022851.
Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab.
Bagnasco D, Bondi B, Caminati M, Nicola S, Pini L, Milanese M, Brussino L, Senna G, Canonica GW, Braido F.
Biomedicines. 2024 Apr 26;12(5):960. doi: 10.3390/biomedicines12050960.
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.
Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GN.
J Clin Oncol. 2017 Apr 1;35(10):1049-1060. doi: 10.1200/JCO.2015.63.1010. Epub 2017 Jan 30.
CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer.
Ye G, Wu G, Zhang C, Wang M, Liu H, Song E, Zhuang Y, Li K, Qi Y, Liao Y.
Front Immunol. 2024 Jun 12;15:1414954. doi: 10.3389/fimmu.2024.1414954. eCollection 2024.
